These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 8516298)

  • 21. Differential regulation of cellular activities by GTPase-activating protein and NF1.
    al-Alawi N; Xu G; White R; Clark R; McCormick F; Feramisco JR
    Mol Cell Biol; 1993 Apr; 13(4):2497-503. PubMed ID: 8455625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schwann cells from neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphological changes.
    Kim HA; Rosenbaum T; Marchionni MA; Ratner N; DeClue JE
    Oncogene; 1995 Jul; 11(2):325-35. PubMed ID: 7624147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurofibromin GTPase-activating protein-related domains restore normal growth in Nf1-/- cells.
    Hiatt KK; Ingram DA; Zhang Y; Bollag G; Clapp DW
    J Biol Chem; 2001 Mar; 276(10):7240-5. PubMed ID: 11080503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NF1 and Neurofibromin: Emerging Players in the Genetic Landscape of Desmoplastic Melanoma.
    Mahalingam M
    Adv Anat Pathol; 2017 Jan; 24(1):1-14. PubMed ID: 27941538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients.
    Basu TN; Gutmann DH; Fletcher JA; Glover TW; Collins FS; Downward J
    Nature; 1992 Apr; 356(6371):713-5. PubMed ID: 1570015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the GAP-related domain of the neurofibromatosis type 1 (NF1) gene in childhood brain tumors.
    Scheurlen WG; Senf L
    Int J Cancer; 1995 Aug; 64(4):234-8. PubMed ID: 7657385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GTPase-activating protein function toward Ras.
    Yunoue S; Tokuo H; Fukunaga K; Feng L; Ozawa T; Nishi T; Kikuchi A; Hattori S; Kuratsu J; Saya H; Araki N
    J Biol Chem; 2003 Jul; 278(29):26958-69. PubMed ID: 12730209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype.
    Yan N; Ricca C; Fletcher J; Glover T; Seizinger BR; Manne V
    Cancer Res; 1995 Aug; 55(16):3569-75. PubMed ID: 7627966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of the tyrosinase gene promoter by neurofibromin.
    Suzuki H; Takahashi K; Yasumoto K; Shibahara S
    Biochem Biophys Res Commun; 1994 Dec; 205(3):1984-91. PubMed ID: 7811291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple transcripts of the neurofibromatosis type 1 gene in human brain and in brain tumours.
    Takahashi K; Suzuki H; Kayama T; Suzuki Y; Yoshimoto T; Sasano H; Shibahara S
    Clin Sci (Lond); 1994 Nov; 87(5):481-5. PubMed ID: 7874833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retroviral integration at the Evi-2 locus in BXH-2 myeloid leukemia cell lines disrupts Nf1 expression without changes in steady-state Ras-GTP levels.
    Largaespada DA; Shaughnessy JD; Jenkins NA; Copeland NG
    J Virol; 1995 Aug; 69(8):5095-102. PubMed ID: 7609078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of TC21/R-Ras2 in enhanced migration of neurofibromin-deficient Schwann cells.
    Huang Y; Rangwala F; Fulkerson PC; Ling B; Reed E; Cox AD; Kamholz J; Ratner N
    Oncogene; 2004 Jan; 23(2):368-78. PubMed ID: 14724565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatic mutations in the neurofibromatosis 1 gene in human tumors.
    Li Y; Bollag G; Clark R; Stevens J; Conroy L; Fults D; Ward K; Friedman E; Samowitz W; Robertson M
    Cell; 1992 Apr; 69(2):275-81. PubMed ID: 1568247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells.
    Bollag G; Clapp DW; Shih S; Adler F; Zhang YY; Thompson P; Lange BJ; Freedman MH; McCormick F; Jacks T; Shannon K
    Nat Genet; 1996 Feb; 12(2):144-8. PubMed ID: 8563751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of neurofibromin mutants that exhibit allele specificity or increased Ras affinity resulting in suppression of activated ras alleles.
    Morcos P; Thapar N; Tusneem N; Stacey D; Tamanoi F
    Mol Cell Biol; 1996 May; 16(5):2496-503. PubMed ID: 8628317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased neurofibromatosis 1 gene expression in astrocytic tumors: positive regulation by p21-ras.
    Gutmann DH; Giordano MJ; Mahadeo DK; Lau N; Silbergeld D; Guha A
    Oncogene; 1996 May; 12(10):2121-7. PubMed ID: 8668337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The GTPase-activating NF1 fragment of 91 amino acids reverses v-Ha-Ras-induced malignant phenotype.
    Nur-E-Kamal MS; Varga M; Maruta H
    J Biol Chem; 1993 Oct; 268(30):22331-7. PubMed ID: 8226742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An expanding role for RAS GTPase activating proteins (RAS GAPs) in cancer.
    Maertens O; Cichowski K
    Adv Biol Regul; 2014 May; 55():1-14. PubMed ID: 24814062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of neurofibromatosis type I gene product as an insoluble GTPase-activating protein toward ras p21.
    Hattori S; Maekawa M; Nakamura S
    Oncogene; 1992 Mar; 7(3):481-5. PubMed ID: 1549362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of NF1 expression in a sporadic schwannoma from a patient without neurofibromatosis.
    Gutmann DH; Silos-Santiago I; Geist RT; Daras M; Rutkowski JL
    J Neurooncol; 1995; 25(2):103-11. PubMed ID: 8543966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.